ISRAEL - Oral Vaccine for Covid-19 Fast-Tracked

Arno Froese

Israel’s MigVax has received a grant of $4.3 million to help develop its COVID-19 oral subunit vaccine tablet from the Coalition of Epidemic Preparedness Innovations (CEPI), based in Norway.

The award is part of a $200m. program to advance the development of vaccines that provide broad protection against COVID-19 variants or future coronaviruses.

“We are gratified that CEPI shares our conviction that a subunit oral vaccine tablet could help the world return to a ‘new normal’ in the ‘day-after-the-pandemic’ reality,” said MigVax CEO David Zigdon. “In fact, 20 months into the COVID crisis, it is clearer than ever that the struggle to keep the disease under control will be nearly as challenging as getting it under control to begin with.

Unlike the Pfizer or Moderna vaccines that use messenger RNA, this is an oral subunit vaccine, meaning the vaccine presents the coronavirus antigen to the immune system without introducing pathogen particles, whole or otherwise.

MIGAL was the first company worldwide to announce that it would put a vaccine on the market.

In exchange for the grant, the organizations have to commit to “achieving equitable access to the outputs of these projects” in line with CEPI’s Equitable Access Policy, which would allow vaccines it helps develop to be used free of charge if and when an outbreak occurs., 4 November 2021

Arno's Commentary

MigVax, part of the MIGAL Research Institute, is located in Israel, Not surprisingly, Israeli scientists are again at the forefront in battling Covid-19. Not injections, but swallowing a tablet is planned to be equally effective. 

It is of interest to us that this type of cutting-edge development is taking place in Israel, a small country with a population of under 9 million people—not among the giants like the EU, US, or China.

When we read our Bible, we find the answer. For example, Deuteronomy 7:6: “For thou art an holy people unto the Lord thy God: the Lord thy God hath chosen thee to be a special people unto himself, above all people that are upon the face of the earth.” One day, Israel will be financially totally independent: “For the Lord thy God blesseth thee, as he promised thee: and thou shalt lend unto many nations, but thou shalt not borrow; and thou shalt reign over many nations, but they shall not reign over thee” (Deuteronomy 15:6). Second Samuel 7:23 asks the question: “And what one nation in the earth is like thy people, even like Israel, whom God went to redeem for a people to himself, and to make him a name, and to do for you great things and terrible, for thy land, before thy people, which thou redeemedst to thee from Egypt, from the nations and their gods?”

We have to keep in mind that there are only about 15 million Jews in the world, representing approximately 0.2% of the global population. Yet when it comes to the recipients of Nobel Prizes, from the nearly 900 individuals who received this honor, 20% are Jews. Thus, we can plainly say, science confirms Scripture.

Arno Froese is the executive director of Midnight Call Ministries and editor-in-chief of the acclaimed prophetic magazines Midnight Call and News From Israel. He has authored a number of well-received books, and has sponsored many prophecy conferences in the U.S., Canada, and Israel. His extensive travels have contributed to his keen insight into Bible prophecy, as he sees it from an international perspective.

Read more from this author

ContactAbout UsPrivacy and Safety